ArticleJournal of medicinal chemistry2017

In Vivo and Mechanistic Studies on Antitumor Lead 7-Methoxy-4-(2-methylquinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-one and Its Modification as a Novel Class of Tubulin-Binding Tumor-Vascular Disrupting Agents.

Mu-Tian Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.